| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |